Digital medical services platform Teladoc Health (NYSE: TDOC) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales fell by 2.5% year on year to $613.8 million. Revenue guidance for the full year exceeded analysts’ estimates, but next quarter’s guidance of $611.5 million was less impressive, coming in 2% below expectations. Its GAAP loss of $0.36 per share was 3.6% below analysts’ consensus estimates.

Is now the time to buy TDOC? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Teladoc’s first quarter results for 2026 reflected the company’s ongoing shift from subscription-based to visit-based revenue models, a transition that has reshaped both revenue mix and customer engagement. Management pointed to enhancements in the 24/7 care platform and the scaling of BetterHelp’s insurance coverage as meaningful contributors to operational improvement. CEO Charles Divita highlighted that the company addressed near-term revenue headwinds by focusing on broadening its care offerings and integrating new AI-driven features, noting, “We see our ability to provide more comprehensive care at scale positioning us well for the opportunities ahead.”

Looking forward, Teladoc’s guidance is built on new product launches leveraging artificial intelligence and the continued rollout of insurance-based mental health services. Management sees insurance adoption as a key catalyst for BetterHelp’s turnaround, with Divita stating, “Insurance really is a major catalyst for the turnaround and growth of BetterHelp in the U.S.” The company expects upcoming product innovations to further differentiate its integrated platform and anticipates that expanded insurance access and improved AI tools will support both revenue growth and operating efficiency throughout the rest of 2026.

Key Insights from Management’s Remarks

Management attributed quarterly performance to the transition toward visit-based models, the rollout of insurance for BetterHelp, and the use of AI to drive efficiency and product differentiation.

• Visit-based revenue transition: The move from subscription to visit-based arrangements accelerated, with management expecting 70% of memberships to be visit-based by year-end. This shift was driven by client preferences aligning with the broader U.S. healthcare system’s fee-for-service approach, and is anticipated to become a net positive for revenue as the year progresses.
• Enhanced 24/7 care platform: Teladoc launched a significantly improved 24/7 care product, expanding covered conditions, providing real-time prescription benefits, and facilitating connections to in-network providers. Early adoption by health plans suggests the platform is beginning to moderate revenue headwinds from the model transition.
• BetterHelp insurance rollout: The insurance-based model for BetterHelp is progressing ahead of expectations, now live in 30 states with over 6,000 credentialed providers. Insurance-covered sessions are running at over 14,000 per week, and insurance-contracted lives reached 150 million, supporting both customer acquisition and engagement.
• AI-driven operational improvements: Teladoc invested in its Pulse intelligence engine and Prism Care platform to leverage artificial intelligence for both patient engagement and administrative efficiency. In BetterHelp, AI-assisted documentation reduced therapist administrative time, supporting scalability as insurance coverage expands.
• International and chronic care growth: International markets and hybrid care models (combining virtual and physical services) posted double-digit growth. Chronic care program enrollment grew, driven by increased adoption of integrated, multi-condition bundles, although the chronic care market remains competitive with ongoing pressure from point solutions.

Drivers of Future Performance

Looking ahead, management expects continued AI-enabled innovation and the expansion of insurance-based offerings to shape both revenue growth and profitability.

• AI-powered product launches: New products integrating artificial intelligence are set to launch later this year, leveraging the Pulse intelligence engine and Prism Care platform. Management believes these advancements will improve care outcomes, differentiate Teladoc in the market, and support higher patient engagement, especially in chronic care and mental health services.
• Scaling BetterHelp insurance: The expansion of insurance access for BetterHelp is expected to drive stabilization and eventual growth within the mental health segment. Management sees insurance as lowering user cost barriers, improving conversion rates, and delivering higher session volumes per user, although building therapist capacity remains a gating factor for scaling.
• Margin improvement and cost discipline: Ongoing cost management, supported by AI-driven productivity tools and focused capital allocation, is expected to drive operating margin expansion. Management highlighted that operational efficiency and the shift to insurance-based models should support improved advertising spend efficiency and margin expansion as more users transition from cash pay to insurance.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will be watching (1) the adoption and impact of new AI-enabled products across Teladoc’s care platform, (2) continued progress in scaling BetterHelp’s insurance offering—particularly therapist onboarding and state expansion, and (3) stabilization and growth in the chronic care segment as bundled, multi-condition solutions gain traction. Execution on international expansion and efficiency initiatives will also be closely monitored for additional signs of sustainable growth.

Teladoc currently trades at $5.96, in line with $5.95 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).

High Quality Stocks for All Market Conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.